TocilizumabV1, Main, Merge, indexHead, AutAff.i

Author's uniq id: Wu Z
Total number of names:
Total number of records with affiliations: 89

Z Wu

NONE (BIBLIO)

000108
000115
000131
000132
000167
000323
000325
000326
000364
000401
000445
000464
000516
000541
000551
000553
000558
000593
000804
000856
000991
000992
000A40
000A76
000A99
000B17
000C11
000C48
000D03
000F04
000F07
000F87
001730
001B17
002355
003502
003A17
004376
004528
004542

Z. Wu

NONE (BIBLIO)

000096
000097
000180
000193
000197
000199
000243
000292
000397
000465
000489
000493
000506
000510
000520
000524
000525
000534
000539
000554
000577
000606
000787
000A10
000A43
000A48
000B74
000D04
000F67

Z.Q. Wu

NONE (BIBLIO)

000A10

ZF Wu

NONE (BIBLIO)

000D44

ZH Wu

NONE (BIBLIO)

000195

ZQ Wu

NONE (BIBLIO)

000528
000603
000754
000796
000C48
000D03
000D12

Zhao Wu

Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, China
République populaire de Chine
Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing
Pékin

000095

Zhaoju Wu

Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, IL.
États-Unis
Illinois
Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago

000118

Zhenzhou Wu

République populaire de Chine Nankai University, Tianjin Tianjin	003627
College of Life Sciences, Nankai University, Tianjin, China (mainland). China (mainland)	001B42
China (mainland)	001B42

Zhiqiang Wu

grid.414252.40000 0004 1761 8894Department of Molecular Biology and Immunology, Institute of Basic Medicine,Chinese PLA General Hospital,No. 28 Fuxing Road, Beijing, 100853 China République populaire de Chine No. 28 Fuxing Road, Beijing Pékin	000561
0000 0004 1761 8894grid.414252.4Molecular & Immunological Department, Bio-therapeutic Department,Chinese PLA General Hospital,No. 28 Fuxing Road, Beijing, 100853 China République populaire de Chine No. 28 Fuxing Road, Beijing Pékin	000C48

Zhixiong Wu

grid.413597.d0000 0004 1757 8802Department of Surgical Intensive Care Unit,Huadong Hospital Affiliated to Fudan University,Shanghai, 200040 People’s Republic of China
République populaire de Chine
Shanghai

000077

Zhong Wu

États-Unis
Stanford University, Palo Alto, CA, USA; University Hospital of Cologne, Cologne, Germany; Rebecca MacDonald Ctr for Arthritis and Autoimmune Disease, Toronto, ON, Canada; Centocor RandD, Inc/University of Pennsylvania School of Medicine, Malvern/Philadelphia, PA, USA; Johnson and Johnson Pharmaceutical Services, Malvern, PA, USA; Karolinska Institutet and Karolinska Hospital, Stockholm, Sweden; Altoona Center for Clinical Research, Duncansville, PA, USA; Centocor Research and Development, Inc., Malvern, PA
Pennsylvanie

003D51

Zunyou Wu

NONE (BIBLIO)

000555

<g><k>Wu Z</k>
<l><g><k>Z Wu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000108</i>
<i>000115</i>
<i>000131</i>
<i>000132</i>
<i>000167</i>
<i>000323</i>
<i>000325</i>
<i>000326</i>
<i>000364</i>
<i>000401</i>
<i>000445</i>
<i>000464</i>
<i>000516</i>
<i>000541</i>
<i>000551</i>
<i>000553</i>
<i>000558</i>
<i>000593</i>
<i>000804</i>
<i>000856</i>
<i>000991</i>
<i>000992</i>
<i>000A40</i>
<i>000A76</i>
<i>000A99</i>
<i>000B17</i>
<i>000C11</i>
<i>000C48</i>
<i>000D03</i>
<i>000F04</i>
<i>000F07</i>
<i>000F87</i>
<i>001730</i>
<i>001B17</i>
<i>002355</i>
<i>003502</i>
<i>003A17</i>
<i>004376</i>
<i>004528</i>
<i>004542</i>
</l>
<n>40</n>
<t>40</t>
</g>
</l>
<n>1</n>
<t>40</t>
</g>
<g><k>Z. Wu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000096</i>
<i>000097</i>
<i>000180</i>
<i>000193</i>
<i>000197</i>
<i>000199</i>
<i>000243</i>
<i>000292</i>
<i>000397</i>
<i>000465</i>
<i>000489</i>
<i>000493</i>
<i>000506</i>
<i>000510</i>
<i>000520</i>
<i>000524</i>
<i>000525</i>
<i>000534</i>
<i>000539</i>
<i>000554</i>
<i>000577</i>
<i>000606</i>
<i>000787</i>
<i>000A10</i>
<i>000A43</i>
<i>000A48</i>
<i>000B74</i>
<i>000D04</i>
<i>000F67</i>
</l>
<n>29</n>
<t>29</t>
</g>
</l>
<n>1</n>
<t>29</t>
</g>
<g><k>Z.Q. Wu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000A10</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>ZF Wu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000D44</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>ZH Wu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000195</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>ZQ Wu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000528</i>
<i>000603</i>
<i>000754</i>
<i>000796</i>
<i>000C48</i>
<i>000D03</i>
<i>000D12</i>
</l>
<n>7</n>
<t>7</t>
</g>
</l>
<n>1</n>
<t>7</t>
</g>
<g><k>Zhao Wu</k>
<l><g><k><affiliation wicri:level="3"><nlm:aff id="aff0001">Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</k>
<l><i>000095</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Zhaoju Wu</k>
<l><g><k><affiliation wicri:level="2"><nlm:affiliation>Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, IL.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago</wicri:cityArea>
</affiliation>
</k>
<l><i>000118</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Zhenzhou Wu</k>
<l><g><k><affiliation wicri:level="3"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Nankai University, Tianjin</wicri:regionArea>
<placeName><settlement type="city">Tianjin</settlement>
</placeName>
</affiliation>
</k>
<l><i>003627</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation><nlm:affiliation>College of Life Sciences, Nankai University, Tianjin, China (mainland).</nlm:affiliation>
<wicri:noCountry code="subField">China (mainland)</wicri:noCountry>
</affiliation>
</k>
<l><i>001B42</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><wicri:noCountry code="subField">China (mainland)</wicri:noCountry>
</k>
<l><i>001B42</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>3</n>
<t>3</t>
</g>
<g><k>Zhiqiang Wu</k>
<l><g><k><affiliation wicri:level="3"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.414252.4</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 1761 8894</institution-id>
<institution>Department of Molecular Biology and Immunology, Institute of Basic Medicine,</institution>
<institution>Chinese PLA General Hospital,</institution>
</institution-wrap>
No. 28 Fuxing Road, Beijing, 100853 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>No. 28 Fuxing Road, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</k>
<l><i>000561</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="3"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1761 8894</institution-id>
<institution-id institution-id-type="GRID">grid.414252.4</institution-id>
<institution>Molecular & Immunological Department, Bio-therapeutic Department,</institution>
<institution>Chinese PLA General Hospital,</institution>
</institution-wrap>
No. 28 Fuxing Road, Beijing, 100853 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>No. 28 Fuxing Road, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</k>
<l><i>000C48</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>2</n>
<t>2</t>
</g>
<g><k>Zhixiong Wu</k>
<l><g><k><affiliation wicri:level="1"><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="GRID">grid.413597.d</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 1757 8802</institution-id>
<institution>Department of Surgical Intensive Care Unit,</institution>
<institution>Huadong Hospital Affiliated to Fudan University,</institution>
</institution-wrap>
Shanghai, 200040 People’s Republic of China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Shanghai</wicri:regionArea>
</affiliation>
</k>
<l><i>000077</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Zhong Wu</k>
<l><g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Stanford University, Palo Alto, CA, USA; University Hospital of Cologne, Cologne, Germany; Rebecca MacDonald Ctr for Arthritis and Autoimmune Disease, Toronto, ON, Canada; Centocor RandD, Inc/University of Pennsylvania School of Medicine, Malvern/Philadelphia, PA, USA; Johnson and Johnson Pharmaceutical Services, Malvern, PA, USA; Karolinska Institutet and Karolinska Hospital, Stockholm, Sweden; Altoona Center for Clinical Research, Duncansville, PA, USA; Centocor Research and Development, Inc., Malvern, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</k>
<l><i>003D51</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Zunyou Wu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000555</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>13</n>
<t>89</t>
</g>

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

	Serveur d'exploration Tocilizumab
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Tocilizumab